Last $52.96 USD
Change Today +1.17 / 2.26%
Volume 129.9K
LGND On Other Exchanges
Symbol
Exchange
NASDAQ GM
OTC US
Frankfurt
OTC US
OTC US
OTC US
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bert W. O'Malley Jr., M.D.

Former Member of Scientific Advisory Board, Ligand Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 75 board members in 1 different organizations across 4 different industries.

See Board Relationships
76--

Background*

Dr. Bert W. O'Malley, Jr., MD., serves as the Editor-in Chief of the ORL, Journal of Oto-Rhino-Laryngology. Dr. O'Malley serves as Tom Thompson Distinguished Service Professor of the Department of Cell Biology at Baylor College of Medicine. Dr. O'Malley Co-founded GeneMedicine, Inc. Dr. O'Malley serves as Co-Director, Head and Neck Cancer Center. He is a Gabriel Tucker Professor of Otorhinolaryngology at University of Pennsylvania Health System Philadelphia, Pennsylvania. ...

Read Full Background

Corporate Headquarters*

11119 North Torrey Pines Road
La Jolla, California 92037

United States

Phone: 858-550-7500
Fax: --

Board Members Memberships*

Former Director
1998-N/A
Former Director
1999-2003
Former Director

Education*

Honorary Doctorate
Karolinska Institutet
BS
University of Pittsburgh
MD
University of Pittsburgh
Honorary Doctorate
New York Medical College
MD
University of Texas Southwestern Medical Center - Dallas

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LGND:US $52.96 USD +1.17

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIGAND PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.